Here are relevant reports on : brain-tumor-therapeutics-market
-
US Medical Gas and Equipment Market by Type [Medical Gas (Oxygen, Nitrous Oxide), Medical Gas Equipment (Flowmeter, Others)], Application [Therapeutics, Diagnostics], End User [Hospital, Home Healthcare] Forecast to 2031
The US Medical Gas and Equipment Market, valued at USD 8.18 million in 2024, stood at USD 8.63 million in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2031, culminating in a forecasted valuation of USD 11.97 million by the end of the period. The growth of the medical gas and equipment market in US is primarily driven by the rising incidence of respiratory and chronic diseases, including COPD, asthma, cardiovascular disorders, and sleep apnea, as well as a rapidly aging population that requires long-term oxygen therapy and critical care support.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Plasma Fractionation Market by Product (Immunoglobulins [Intravenous, Subcutaneous], Albumin, Protease Inhibitors, VWF), Application (Preclinical, Therapeutics), Therapy (Neurology, Immunology, Hematology, Rheumatology), Region - Global Forecast to 2031
The global plasma fractionation market is projected to reach USD 52.58 billion by 2031, growing at a CAGR of 7.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
mRNA Therapeutics Market by Product (Vaccines, Drugs), Application (Oncology, Rare Diseases, Infectious Diseases, Other Applications), End User (Hospitals & Clinics, Research Settings) - Global Forecast to 2027
The global mRNA therapeutics market is projected to reach USD ~35 billion by 2027 from USD 32 billion in 2022, at a CAGR of ~2% between 2022 and 2027.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020
The global virus filtration market size is projected to grow at a CAGR of 12.3%. Virus filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.
- Published: April 2016
- Price: $ 4950
- TOC Available:
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
The global custom antibody market, valued at US$539 million in 2023, stood at US$579 million in 2024 and is projected to advance at a resilient CAGR of 9.2% from 2024 to 2029, culminating in a forecasted valuation of US$901 million by the end of the period. The market's growth is mainly driven by government funding and support for research in antibody-related fields, coupled with the expansion into translational medicine.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Personalized Medicine Market by Product (Personalized Medicine Testing, Personalized Medicine Therapeutics), Application (Oncology, Neurology, Cardiology) - Global Forecast to 2027
The global personalized medicine market is projected to reach USD ~500 billion by 2027 from USD 300 Billion in 2022, at a CAGR of 11% during the forecast period
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Product (Commercial, Pipeline), Format (mAb, ADC, Fragment), Target (PDL1, Cytokine), Therapy area (Oncology, Neurology, Inflammatory), Source (Human, Humanized), ROA (IV, SC), Region, Competition - Global Forecast to 2035
The global antibody therapeutics market is projected to reach USD 597.1 billion by 2035, growing at a CAGR of 7.5% during the forecast period (2026–2035). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecasts to 2025
The global osteoarthritis therapeutics market growth is primed to transition from USD 7.3 billion in 2020 to USD 11.0 million by 2025, showcasing a strong CAGR of 8.7%.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Bioconjugation Market by Product (Consumables, Instruments (Chromatography, Spectrometry)), Service (Conjugation, Analytical), Technique (Chemical, Click Chemistry), Biomolecule (Antibodies), Application (Therapeutics (ADC), R&D) - Global Forecast to 2029
The global bioconjugation market, valued at US$4.78 billion in 2023, stood at US$5.27 billion in 2024 and is projected to advance at a resilient CAGR of 15.6% from 2024 to 2029, culminating in a forecasted valuation of US$10.86 billion by the end of the period. The bioconjugation market is experiencing significant growth with the advancement of bioconjugation technologies, which increase precision, efficacy, and safety in therapeutic & diagnostic applications.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Europe Medical Gas and Equipment Market by Type [Medical Gas (Oxygen, Nitrous Oxide), Medical Gas Equipment (Flowmeter, Others)], Application [Therapeutics, Diagnostics], End User [Hospital, Home Healthcare] - Regional Forecast to 2031
The Europe Medical Gas and Equipment Market, valued at US5D .71 billion in 2024, stood at USD 6.00 billion in 2025 and is projected to advance at a resilient CAGR of 5.3% from 2025 to 2031, culminating in a forecasted valuation of USD 8.19 billion by the end of the period. The Europe medical gas and equipment market is expanding because of factors such as healthcare demand resulting from an aging population, the prevalence of chronic and respiratory diseases, and higher surgical and ICU volumes.
- Published: October 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
